References
  1. Makdishi G, Wang I. Extra Corporeal Membrane Oxygenation (ECMO) review of a lifesaving technology. J Thorac Dis 2015;7(7):E166-E174. https://doi.org/10.3978/j.issn.2072-1439.2015.07.17.
  2. Allen S, Holena D, McCunn M, et al . A Review of the Fundamental Principles and Evidence Base in the Use of Extracorporeal Membrane Oxygenation (ECMO) in Critically Ill Adult Patients. J Intensive Care Med 2011;26(1):13-26. https://doi.org/10.1177/0885066610384061.
  3. Extracorporeal Life Support Organization - ECMO and ECLS > Registry > Statistics > International Summary. https://www.elso.org/Registry/Statistics/InternationalSummary.aspx. Accessed March 20, 2020.
  4. Khorsandi M, Shaikhrezai K, Prasad S, et al . Advanced mechanical circulatory support for post-cardiotomy cardiogenic shock: a 20-year outcome analysis in a non-transplant unit. J Cardiothorac Surg 2016;11:29. https://doi.org/10.1186/s13019-016-0430-2.
  5. Khorsandi M, Dougherty S, Sinclair A, et al. A 20-year multicentre outcome analysis of salvage mechanical circulatory support for refractory cardiogenic shock after cardiac surgery. J Cardiothorac Surg 2016;8(11):151. https://doi.org/10.1186/s13019-016-0545-5.
  6. Rastan AJ, Dege A, Mohr M, et al . Early and late outcomes of 517 consecutive adult patients treated with extracorporeal membrane oxygenation for refractory postcardiotomy cardiogenic shock. J Thorac Cardiovasc Surg 2010;139(2):302-311. https://doi.org/10.1016/j.jtcvs.2009.10.043.
  7. Li CL, Wang H, Jia M, et al . The early dynamic behavior of lactate is linked to mortality in postcardiotomy patients with extracorporeal membrane oxygenation support: a retrospective observational study. J Thorac Cardiovasc Surg2015;149(5):1445–50. https://doi.org/10.1016/j.jtcvs.2014.11.052.
  8. Hsu P, Chen J, Hong G. Extracorporeal membrane oxygenation for refractory cardiogenic shock after cardiac surgery: predictors of early mortality and outcome from 51 adult patients. Eur J Cardiothorac Surg 2010;37(2):328-333. https://doi.org/10.1016/j.ejcts.2009.07.033.
  9. Wu MY, Lin PJ, Lee MY, et al . Using extracorporeal life support to resuscitate adult postcardiotomy cardiogenic shock: treatment strategies and predictors of short-term and midterm survival.Resuscitation 2010;81(9):1111–6. https://doi.org/10.1016/j.resuscitation.2010.04.031.
  10. Elsharkawy HA, Li L, Sakr WA, et al . Outcome in Patients Who Require Venoarterial Extracorporeal Membrane Oxygenation Support After Cardiac Surgery. J Cardiothoracic Vasc Anesth2010;24(6):946-951. https://doi.org/10.1053/j.jvca.2010.03.020.
  11. Rubino A, Costanzo D, Stanszus,et al . Central Veno-Arterial Extracorporeal Membrane Oxygenation (C-VA-ECMO) After Cardiothoracic Surgery: A Single-Center Experience. J Cardiothorac Vasc 2018;32(3):1169-1174. https://doi.org/10.1053/j.jvca.2017.12.003.
  12. Slottosch I, Liakopoulos O, Kuhn E, et al . Outcomes after peripheral extracorporeal membrane oxygenation therapy for postcardiotomy cardiogenic shock: a single-center experience. J Surg Res 2013;181(2):47–55. https://doi.org/10.1016/j.jss.2012.07.030.
  13. Mikus E, Tripodi A, Calvi S, et al . CentriMag Venoarterial extracorporeal membrane oxygenation support as treatment for patients with refractory Postcardiotomy Cardiogenic shock. ASAIO J2013;59(1):18–23. https://doi.org/10.1097/MAT.0b013e3182768b68.
  14. Frenckner B, Broman M, Broomé M. Position of draining venous cannula in extracorporeal membrane oxygenation for respiratory and respiratory/circulatory support in adult patients. Crit Care2018;22:163. https://doi.org/10.1186/s13054-018-2083-0.
  15. Rao P, Khalpey Z, Smith R, et al . Venoarterial Extracorporeal Membrane Oxygenation for Cardiogenic Shock and Cardiac Arrest.Circ Heart Fail 2018;11:e004906. https://doi.org/10.1161/CIRCHEARTFAILURE.118.004905.
  16. Flécher E, Anselmi A, Corbineau H, et al . Current aspects of extracorporeal membrane oxygenation in a tertiary referral centre: determinants of survival at follow-up. Eur J Cardio-Thoracic Surg 2014;46(4):655-671. https://doi.org/10.1093/ejcts/ezu029.
  17. Acker MA. Mechanical circulatory support for patients with acute-fulminant myocarditis. Ann Thorac Surg 2001;71:S73-S76. https://doi.org/10.1016/S0003-4975(00)02628-X.
  18. Stewart GC, Giverts MM. Mechanical circulatory support for advanced heart failure: patients and technology in evolution.Circulation 2012;125:1304–15. https://doi.org/10.1161/CIRCULATIONAHA.111.060830.
  19. Peek GJ, Mugford M, Tiruvoipati R, et al . Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multi-centre randomised controlled trial. Lancet2009;372:1351-63. https://doi.org/10.1016/S0140-6736(09)61069-2.
  20. McLaren G, Combes A, Bartlett RH. Contemporary extracorporeal membrane oxygenation for adult respiratory failure: life support in the new era. Intensive Care Med 2012;38:210-220. https://doi.org/10.1007/s00134-011-2439-2.
  21. Pipeling MR, Fan E. Therapies for refractory hypoxaemia in acute respiratory distress syndrome. JAMA 2010;304:2521-2527. https://doi.org/10.1001/jama.2010.1752.
  22. Onorati F, Quintana E, Dean Z, et al . (2020). Aortic valve replacement for aortic stenosis in low-, intermediate-, and high-risk patients: preliminary results from a prospective multicenter Registry.J Cardiothorac Vasc Anesth , https://doi.org/10.1053/j.jvca.2020.02.045.
  23. DiVita M, Visveswaran GK, Naji P, et al . Emergent TandemHeart – ECMO for acute severe mitral regurgitation with cardiogenic shock and hypoxaemia: a case series. Eur Heart J 2020;4(1):1-6. https://doi.org/10.1093/ehjcr/ytz234.
  24. Ziganshin BA, Elefteriades JA. Deep hypothermic circulatory arrest.Ann Cardiothorac Surg 2013;2(3):303-315. https://doi.org/10.3978/j.issn.2225-319X.2013.01.05.
  25. González-Ibarra FP, Varon J, López-Meza EG. Therapeutic hypothermia: critical review of the molecular mechanisms of action. Front Neurol 2011;2:4. https://doi.org/10.3389/fneur.2011.00004.
  26. Conolly S, Arrowsmith JE, Klein AA. Deep hypothermic circulatory arrest. BJA Educ 2010;10(5):138-142. https://doi.org/10.1093/bjaceaccp/mkq024.
  27. Tabbutt S, Ghanayem N, Ravishankar, et al . Risk factors for hospital morbidity and mortality after the Norwood procedure: A report from the Paediatric Heart Network Single Ventricle Reconstruction trial. J Thorac Cardiovasc Surg 2012;144(4):882-895. https://doi.org/10.1016/j.jtcvs.2012.05.019.
  28. Gaynor JW, Mahle WT, Cohen MI, et al . Risk factors for mortality after the Norwood procedure. Eur J Cardiothorac Surg2002;22:82–89. https://doi.org/10.1016/S1010-7940(02)00198-7.
  29. Mahle WT, Hu C, Trachtenberg F, et al . Heart Failure Following The Norwood Procedure: An Analysis Of The Single Ventricle Reconstruction Trial. J Heart Lung Transplant2018;37(7):879-885. https://doi.org/10.1016/j.healun.2018.02.009.
  30. Rungatscher A, Tessari M, Stranieri C, et al . Oxygenator Is the Main Responsible for Leukocyte Activation in Experimental Model of Extracorporeal Circulation: A Cautionary Tale. Mediat Inflamm2015;2015:484979. https://doi.org/10.1155/2015/484979.
  31. Millar JE, Fanning JP, McDonald CI, et al . The inflammatory response to extracorporeal membrane oxygenation (ECMO): A review of the pathophysiology. Crit Care 2016;20(1):1-10. https://doi.org/10.1186/s13054-016-1570-4.
  32. Dieleman JM, van Paassen J, van Dijk D, et al . Prophylactic corticosteroids for cardiopulmonary bypass in adults. Cochrane Database Syst Rev 2011. https://doi.org/10.1002/14651858.cd005566.pub3.
  33. Dieleman JM, Nierich AP, Rosseel PM, et al . Intraoperative high-dose dexamethasone for cardiac surgery: A randomized controlled trial. JAMA 2012;308(17):1761-1767. https://doi.org/10.1001/jama.2012.14144.
  34. Qiang Y, Liang G, Yu L. Human amniotic mesenchymal stem cells alleviate lung injury induced by ischemia and reperfusion after cardiopulmonary bypass in dogs. Lab Investig2016;96(5):537-546. https://doi.org/10.1038/labinvest.2016.37.
  35. Bruenger F, Kizner L, Weile J, et al . First successful combination of ECMO with cytokine removal therapy in cardiogenic septic shock: A case report. Int J Artif Organs2015;38(2):113-116. https://doi.org/10.5301/ijao.5000382.
  36. Yang F, Hou D, Wang J, et al . Vascular complications in adult postcardiotomy cardiogenic shock patients receiving venoarterial extracorporeal membrane oxygenation. Ann Intensive Care2018;8(1):72. https://doi.org/10.1186/s13613-018-0417-3.
  37. Bonicolini E, Martucci G, Simons J, et al . Limb ischemia in peripheral veno-arterial extracorporeal membrane oxygenation: A narrative review of incidence, prevention, monitoring, and treatment.Crit Care 2019. https://doi.org/10.1186/s13054-019-2541-3.
  38. Girn HRS, Ahilathirunayagam S, Mavor AID, et al . Basic science review: Reperfusion syndrome: Cellular mechanisms of microvascular dysfunction and potential therapeutic strategies. Vasc Endovasc Surg 2007;41(4):277-293. https://doi.org/10.1177/1538574407304510.
  39. Jang WJ, Cho YH, Park TK, et al . Fluoroscopy-guided simultaneous distal perfusion as a preventive strategy of limb ischemia in patients undergoing extracorporeal membrane oxygenation.Ann Intensive Care 8 2018;8(1):101. https://doi.org/10.1186/s13613-018-0445-z.
  40. Choi MS, Sung K, Cho YH. Clinical pearls of venoarterial extracorporeal membrane oxygenation for cardiogenic shock.Korean Circ J 2019;49(8):657-677. https://doi.org/10.4070/kcj.2019.0188.
  41. Badheka A, Stucker SE, Turek JW, et al . Efficacy of Flow Monitoring during ECMO. ASAIO Journal 2017;63(4):496-500. https://doi.org/10.1097/MAT.0000000000000538.
  42. Doll N, Kiaii B, Borger M, et al . Five-Year results of 219 consecutive patients treated with extracorporeal membrane oxygenation for refractory postoperative cardiogenic shock. Ann Thorac Surgery 2004;77(1):151-157. https://doi.org/10.1016/S0003-4975(03)01329-8.
  43. Kasirajan V, Smedira NG, McCarthy JF, et al . Risk factors for intracranial hemorrhage in adults on extracorporeal membrane oxygenation. Eur J Cardiothorac Surg 1999;15(4):508-514. https://doi.org/10.1016/S1010-7940(99)00061-5.
  44. Thiagarajan RR, Barbaro RP, Rycus PT, et al . Extracorporeal Life Support Organization Registry International Report 2016.ASAIO Journal 2017;63(1):60-67. https://doi.org/10.1097/MAT.0000000000000475.
  45. Biffi S, di Bella S, Scaravilli V, et al . Infections during extracorporeal membrane oxygenation: epidemiology, risk factors, pathogenesis and prevention. Int Antimicrob Agents2017;50(1):9-16. https://doi.org/10.1016/j.ijantimicag.2017.02.025.
  46. Khorsandi M, Dougherty S, Bouamra O, et a l. Extra-corporeal membrane oxygenation for refractory cardiogenic shock after adult cardiac surgery: A systematic review and meta-analysis. J Cardiothorac Surg 2017;12(1):55. https://doi.org/10.1186/s13019-017-0618-0.
  47. Ge M, Pan T, Wang JX, et al . Outcomes of early versus delayed initiation of extracorporeal life support in cardiac surgery. J Cardiothorac Surg 2019;14(1):129. https://doi.org/10.1186/s13019-019-0950-7.
  48. Madhani SP, Frankowski BJ, Burgreen GW, et al . In vitro and in vivo evaluation of a novel integrated wearable artificial lung.J Heart Lung Transplant 2017;36(7):806-811. https://doi.org/10.1016/j.healun.2017.02.025.
  49. Wu ZJ, Zhang T, Bianchi G, et al . Thirty-day in-vivo performance of a wearable artificial pump-lung for ambulatory respiratory support. Ann Thorac Surg 2012;93(1):274-281. https://doi.org/10.1016/j.athoracsur.2011.08.076.
  50. Bain JC, Turner DA, Rehder KJ, et al . Economic outcomes of extracorporeal membrane oxygenation with and without ambulation as a bridge to lung transplantation. Respir Care 2016;61(1):1-7. https://doi.org/10.4187/respcare.03729.
  51. Scottish Government T. Scottish Government Health Directorates The Provision of Non-H1N1 Adult Respiratory Extra Corporeal Membrane Oxygenation (ECMO) in the Medium and Longer Term for Scotland ECMO Expert Group Report and Recommendations December 2009 2 CONTENTS.
  52. Westaby S, Taggart D. Inappropriate restrictions on life saving technology. Heart 2012;98(15):1117-9. https://doi.org/10.1136/heartjnl-2011-301365.
  53. Sedgwick C, Gati S, Sharma S. Extra corporeal membrane oxygenation (ECMO) devices in all heart attack centres in the UK?. Br J Cardiol 2012;19:102-03. https://doi.org/10.5837/bjc.2012.021.
  54. Westaby S, de Silva R, George S, et al . Lessons learnt from a tragic loss - But will things improve? Br J Cardiol2012;19:141-3. https://doi.org/10.5837/bjc.2012.027.
  55. Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected. https://www.who.int/publications-detail/clinical-management-of-severe-acute-respiratory-infection-when-novel-coronavirus-(ncov)-infection-is-suspected. Accessed March 20, 2020.
  56. MacLaren G, Fisher D, Brodie D. Preparing for the Most Critically Ill Patients With COVID-19: The Potential Role of Extracorporeal Membrane Oxygenation. JAMA 2020. https://doi.org/10.1001/jama.2020.2342.
  57. Henry BM. COVID-19, ECMO, and lymphopenia: a word of caution.Lancet Respir Med 2020. https://doi.org/10.1016/S2213-2600(20)30119-3.